Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Boulware

Showing results (201-210 of 350) with videos related to

Pageof 35
Sort By:
Emerging Infectious Diseases|January 1, 2014
Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrastDavid R Boulware, Melissa A Rolfes, Radha Rajasingham, et al.
Wellcome Open Research|July 21, 2018
Can improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in UgandaFiona V Cresswell, Ananta S Bangdiwala, Nathan C Bahr, et al.
Nature Communications|December 18, 2023
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapyAbigail R Gress, Christine E Ronayne, Joshua M Thiede, et al.
Wellcome Open Research|September 4, 2018
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)Fiona V Cresswell, Kenneth Ssebambulidde, Daniel Grint, et al.
Journal of Clinical and Translational Science|July 2, 2025
Participant experiences in a decentralized clinical trial using digital health technologies: The ACTIV-6 studyCarrie Reale, Janelle Faiman, Russ Beebe, et al.
The Lancet. Infectious Diseases|September 19, 2017
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort studyNathan C Bahr, Edwin Nuwagira, Emily E Evans, et al.
Open Forum Infectious Diseases|February 26, 2025
Neurocognitive Impairment Among Cryptococcal Meningitis Survivors in Uganda, a Prospective Cohort StudyLaura Nsangi, Kathy Huppler Hullsiek, Biyue Dai, et al.
Medical Mycology|November 6, 2019
Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for managementKatelyn A Pastick, Elizabeth Nalintya, Lillian Tugume, et al.
Journal of Clinical Microbiology|June 2, 2021
Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal MeningitisKiiza Kandole Tadeo, Audrey Nimwesiga, Richard Kwizera, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Impact of Cerebrospinal Fluid Leukocyte Infiltration and Neuroimmmune Mediators on Survival with HIV-Associated Cryptococcal MeningitisSamuel Okurut, David R Boulware, Yukari C Manabe, et al.
Pageof 35

Showing results (201-210 of 350) with videos related to

Sort By:
Pageof 35
Emerging Infectious Diseases|January 1, 2014
Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrastDavid R Boulware, Melissa A Rolfes, Radha Rajasingham, et al.
Wellcome Open Research|July 21, 2018
Can improved diagnostics reduce mortality from Tuberculous meningitis? Findings from a 6.5-year cohort in UgandaFiona V Cresswell, Ananta S Bangdiwala, Nathan C Bahr, et al.
Nature Communications|December 18, 2023
Recently activated CD4 T cells in tuberculosis express OX40 as a target for host-directed immunotherapyAbigail R Gress, Christine E Ronayne, Joshua M Thiede, et al.
Wellcome Open Research|September 4, 2018
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)Fiona V Cresswell, Kenneth Ssebambulidde, Daniel Grint, et al.
Journal of Clinical and Translational Science|July 2, 2025
Participant experiences in a decentralized clinical trial using digital health technologies: The ACTIV-6 studyCarrie Reale, Janelle Faiman, Russ Beebe, et al.
The Lancet. Infectious Diseases|September 19, 2017
Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort studyNathan C Bahr, Edwin Nuwagira, Emily E Evans, et al.
Open Forum Infectious Diseases|February 26, 2025
Neurocognitive Impairment Among Cryptococcal Meningitis Survivors in Uganda, a Prospective Cohort StudyLaura Nsangi, Kathy Huppler Hullsiek, Biyue Dai, et al.
Medical Mycology|November 6, 2019
Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for managementKatelyn A Pastick, Elizabeth Nalintya, Lillian Tugume, et al.
Journal of Clinical Microbiology|June 2, 2021
Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal MeningitisKiiza Kandole Tadeo, Audrey Nimwesiga, Richard Kwizera, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2024
Impact of Cerebrospinal Fluid Leukocyte Infiltration and Neuroimmmune Mediators on Survival with HIV-Associated Cryptococcal MeningitisSamuel Okurut, David R Boulware, Yukari C Manabe, et al.
Pageof 35